Clinical Trials Logo

Chronic Heart Failure With Preserved Ejection Fraction clinical trials

View clinical trials related to Chronic Heart Failure With Preserved Ejection Fraction.

Filter by:
  • None
  • Page 1

NCT ID: NCT03547583 Recruiting - Clinical trials for Chronic Heart Failure With Preserved Ejection Fraction

Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF

VITALITY-HFpEF
Start date: June 15, 2018
Phase: Phase 2
Study type: Interventional

The primary hypothesis in this trial is that the treatment with vericiguat 10 mg or 15 mg in patients with HFpEF improves the KCCQ PLS (Kansas City Cardiomyopathy Questionnaire Physical limitation score) compared to placebo after 24 weeks of treatment.